Cargando…
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
Background: Metformin, a commonly used antidiabetic medication, is available in both an immediate-release (IR) formulation and a long-acting formulation (metformin extended-release; XR). Objective: We performed a systematic review to compare the effectiveness, safety, and patient compliance and sati...
Autores principales: | Tan, Jixue, Wang, Yang, Liu, Song, Shi, Qingyang, Zhou, Xu, Zhou, Yiling, Yang, Xiaoling, Chen, Pingshan, Li, Sheyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165304/ https://www.ncbi.nlm.nih.gov/pubmed/34079464 http://dx.doi.org/10.3389/fphar.2021.669814 |
Ejemplares similares
-
Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey
por: Liu, Chang, et al.
Publicado: (2021) -
Metformin acts as a dual glucose regulator in mouse brain
por: Jin, Bo-Yeong, et al.
Publicado: (2023) -
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
por: Bailey, Clifford J., et al.
Publicado: (2022) -
Development and Evaluation of Novel Metformin Derivative Metformin Threonate for Brain Ischemia Treatment
por: Zhang, Gufang, et al.
Publicado: (2022) -
The anti-diabetic effects of metformin are mediated by regulating long non-coding RNA
por: Chang, Wenguang, et al.
Publicado: (2023)